Active, Not Recruiting
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
NCT06088290
- Conditions
- Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- Mayo Clinic Hospital - Phoenix Phoenix, Arizona, United States
- Precision NextGen Oncology & Research Center Beverly Hills, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Norris Comprehensive Cancer Center Los Angeles, California, United States